Goldman Sachs’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Goldman Sachs’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-354,818	Closed	-$12.8M	–	6556
2020 Q4	$12.8M	Buy	354,818 +132,556	+60%	+$4.64M	﹤0.01%	2247
2020 Q3	$6.24M	Sell	222,262 -225,980	-50%	-$8M	﹤0.01%	2727
2020 Q2	$19.4M	Buy	448,242 +239,300	+115%	+$10.8M	0.01%	1706
2020 Q1	$7.94M	Buy	208,942 +21,442	+11%	+$836K	﹤0.01%	2262
2019 Q4	$5.09M	Buy	+187,500	New	+$4.73M	﹤0.01%	2948

Goldman Sachs's VIE Position: Q1 2021 in Review

Goldman Sachs sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 354,818 shares — an estimated $12.8M sold.

Goldman Sachs first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $19.4M in Q2 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Goldman Sachs reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Goldman Sachs sold 354,818 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $12.8M.
Goldman Sachs first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Goldman Sachs's Viela Bio, Inc. Common Stock position peaked at $19.4M in Q2 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Goldman Sachs's 13F filing for Q1 2021, filed 17 May 2021.